Iconovo receives grant from Sweden’s innovation agency

Iconovo has received a 350 000 USD grant from Sweden’s innovation agency Vinnova. The development project includes optimization of ICOone and adaptation for high-volume low-cost commercial manufacturing. ICOone is primary intended for inhaled vaccines but is also suitable for biomolecules and high cost drugs.